Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study
Kohei Fujita, Paul Elkington, Gil Redelman‐Sidi, Osamu Kanai, Yuki Yamamoto, Takuma Imakita, Misato Okamura, Koichi Nakatani, Tadashi Mio
Topics & Concepts
MedicineNivolumabAtezolizumabPembrolizumabTuberculosisImmunotherapyInternal medicineLung cancerDurvalumabOncologyInterferon gamma release assayProspective cohort studyActive immunotherapyImmunologyCancerLatent tuberculosisMycobacterium tuberculosisPathologyCancer Immunotherapy and BiomarkersTuberculosis Research and EpidemiologyCancer therapeutics and mechanisms